Pioneering nonequilibrium imaging of membrane proteins to accelerate breakthrough therapeutics
NOVATARG has pioneered a nonequilibrium imaging approach to solve structures of difficult membrane proteins involved in cancer, diabetes, cardiovascular, neurodegenerative, and infectious diseases. The platform dramatically improves the speed, specificity, and cost of identifying membrane protein therapeutic targets and developing clinical drug candidates.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Create Free Account
